SpaceWar.com - Your World At War
Iraq security forces seize 12 million benzhexol pills
Baghdad, May 5 (AFP) May 05, 2023
Iraqi security forces said Friday they had seized 12 million pills of the antispasmodic drug benzhexol, used in the treatment of Parkinson's disease but also abused as a hallucinogen.

National Security officers recovered the haul from a warehouse in east Baghdad in an operation in which they also made six arrests.

Iraqi security forces have intensified anti-narcotics operations in recent months, with several high-profile seizures reported.

Sharing borders with Syria as well as Kuwait and Saudi Arabia, Iraq has served as a major conduit for traffickers of captagon, an amphetamine which is primarily produced in Syria but has its largest market in the wealthy Gulf states.


ADVERTISEMENT




Space News from SpaceDaily.com
PLD Space selected as leading contender for ESA sovereign launch initiative
UK thermal satellite firm wins ESA contract to deliver real time climate and security insights
UK opens competitive bid for GBP 75 million orbital cleanup mission

24/7 Energy News Coverage
China speeds up renewables building spree: report
French giant EDF will take 12.5 pecent stake in new UK nuclear plant
Major US teachers union teams up with AI giants

Military Space News, Nuclear Weapons, Missile Defense
BlackSky expands Gen-3 access to bolster Ukraine-focused intelligence operations
Maxar secures $205 million in multi-year deals to boost space capabilities across MEA
K2 Space validates satellite systems in orbit and fires record-breaking thruster

24/7 News Coverage
The long slow death of Norway's wild salmon
Beijing decries 'discriminatory' ban on Chinese purchases of US farmland
China's 'new farmers' learn to livestream in rural revitalisation



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.